DK 021:2015 33600000-6 Pharmaceutical products: Levofloxacin eye drops solution 5 mg/ml vial 5 ml; Ketorolac eye drops 5mg/ml per 5ml; Dexamethasone eye drops 1mg/ml per 5 ml; Oxybuprocaine eye drops, solution 0.4%, 10 ml in a dropper container

This tender is for the procurement of several types of ophthalmic medications, categorized under pharmaceutical products (CPV 33600000-6). The specific items include Levofloxacin eye drops (5 mg/ml, 5 ml vial), Ketorolac eye drops (5 mg/ml, 5 ml), Dexamethasone eye drops (1 mg/ml, 5 ml), and Oxybuprocaine eye drops (0.4%, 10 ml in a dropper container). Detailed classifications, including ATC and INN codes, are provided for Ketorolac and Dexamethasone, specifying their therapeutic class, formulation, dosage, volume, and packaging type. Levofloxacin is classified under systemic anti-infectives, while Oxybuprocaine falls under medications for the nervous system and sensory organs. This procurement is essential for healthcare facilities to ensure the availability of necessary eye treatments for patients. The tender likely aims to secure a supply of these critical medications for a specified period, ensuring continuity of care for eye conditions. The detailed specifications highlight the need for precise pharmaceutical products that meet established medical standards and patient requirements.

This is a supplies contract in the health and medical services sector, with a focus on Hospitals and Pharmaceuticals. Located in Ukraine, Europe, this opportunity is open to firms and consortiums, with an estimated budget of UAH 141,300.

Published through ProZorro Ukraine, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.